Biopharmx Corp  (BPMX)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Biopharmx's Leverage Ratio for Trailing Twelve Months Period

BPMX's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth

BPMX Leverage Ratio for Trailing Twelve Months Period

(Jan 31 2020)
IV. Quarter
(Oct 31 2019)
III. Quarter
(Jul 31 2019)
II. Quarter
(Apr 30 2019)
I. Quarter
(Jan 31 2019)
IV. Quarter
Y / Y Equity Growth - 21.32 % -48.11 % -82.69 % -74.41 %
Y / Y Total Liabilities Growth -27.5 % -49.3 % -34.91 % -20.59 % -21.94 %
Leverage Ratio for Trailing Twelve Months Period 1.97 1.51 1.83 1.48 0.82
Total Ranking # 2881 # 2166 # 0 # 0 # 0
Seq. Equity Growth - -67.59 % 55.34 % 9.71 % 119.63 %
Seq. Total Liabilities Growth 7.83 % -23.18 % -19.14 % 8.23 % -24.58 %

Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis In the IV. Quarter company had stockholder deficit.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Drugs industry 151 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Biopharmx. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are BPMX's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 152
Sector # 621
S&P 500 # 2881

Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
13.29 2.77 0.62
(Jul 31 2017)   (Jan 31 2019)

Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Jan 31 2020, within Biotechnology & Drugs Industry Leverage Ratio for Trailing Twelve Months Period
Amgen Inc   4.68 
Apollo Endosurgery inc   3.75 
United Cannabis Corp  3.70 
Adma Biologics Inc   3.67 
Phathom Pharmaceuticals Inc   3.45 
Aslan Pharmaceuticals Ltd  3.27 
Cytomx Therapeutics Inc   3.18 
89bio Inc   3.10 
Champions Oncology Inc   3.03 
Biopharmx Corp  2.64 
Alder Biopharmaceuticals Inc  2.52 
Cure Pharmaceutical Holding Corp   2.49 
Orgenesis Inc   2.41 
Axovant Gene Therapies Ltd.  2.34 
Aytu Bioscience Inc  2.33 
Sienna Biopharmaceuticals, Inc.  2.20 
Cyclo Therapeutics Inc   2.19 
Intelgenx Technologies Corp   2.00 
Oyster Point Pharma Inc   1.96 
Sun Biopharma Inc   1.90 
Cerecor Inc   1.85 
Wave Life Sciences Ltd   1.80 
Sellas Life Sciences Group Inc   1.77 
Aevi Genomic Medicine, Inc.  1.77 
Cabaletta Bio Inc   1.76 
Nanostring Technologies Inc   1.72 
Vaxart Inc   1.69 
Gilead Sciences Inc   1.68 
Pivot Pharmaceuticals Inc.  1.64 
Allergan plc  1.55 


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

OMEX's Profile

Stock Price

OMEX's Financials

Business Description


Charts & Quotes

OMEX's News


OMEX's Competitors

Customers & Markets

Economic Indicators

OMEX's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071